On the problem of aspiration therapy of ovarian endometriomas

A.I. Davydov, M.B. Tairova
In: Voprosy ginekologii, akušerstva i perinatologii · 2017 · vol. 16(3) , pp. 68–71 · doi:10.20953/1726-1678-2017-3-68-71 · W2741069203
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-10 ⓘ

Aspiration therapy of ovarian endometriomas is discussed, noting a 43.2% relapse rate within 12 months and 37.3% pregnancy rate, emphasizing patient selection and hormone therapy compliance for favorable outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

This article discusses disputable issues in aspiration therapy for ovarian endometriomas, contrasting it with sclerosing therapy. The authors report a relatively high 43.2% incidence of relapses within 12 months after sclerosing therapy, while pregnancy occurred in 37.3% of women during that period, with childbirth in all pregnancies. They state that aspiration therapy requires careful patient selection and that favorable outcomes depend in part on adherence to hormone therapy. This paper is centrally about endometriosis—specifically aspiration therapy and relapse/pregnancy outcomes in women with ovarian endometriomas.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,420 characters · extracted from oa-doi-fallback · click to expand
Gynecology, Obstetrics and Perinatology - Gynecology, Obstetrics and Perinatology - 2017 volume 16 issue 3 On the problem of aspiration therapy of ovarian endometriomas Authors / Institutions Aleksandr I. Davydov / Marina B. Tairova / The article discusses disputable problems of spiration therapy of ovarian endometriomas. A comparatively high (43.2%) incidence of relapses of endometriomsa within a 12-month follow-up after sclerosing therapy has been noted. At the same time, pregnancy occurred in 37.3% of women during this period, later ending with childbirth in 100% of cases. Aspiration therapy of ovarian endometriomsa presupposes a careful selection of patients for such intervention. Its favourable outcomes in many respects depend on hormone therapy compliance. Key words: aspiration therapy, sclerosing therapy, ovarian endometriomas. For citation: Davydov A.I., Tairova M.B. On the problem of aspiration therapy of ovarian endometriomas. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2017; 16(3): 68–71. (In Russian). DOI: 10.20953/1726-1678-2017-3-68-71 Key words: aspiration therapy, sclerosing therapy, ovarian endometriomas. For citation: Davydov A.I., Tairova M.B. On the problem of aspiration therapy of ovarian endometriomas. Vopr. ginekol. akus. perinatol. (Gynecology, Obstetrics and Perinatology). 2017; 16(3): 68–71. (In Russian). DOI: 10.20953/1726-1678-2017-3-68-71

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK